Literature DB >> 3028995

Alterations of visual contrast sensitivity in Parkinson's disease.

W Skrandies, I Gottlob.   

Abstract

Contrast sensitivity functions were determined in a population of 18 patients suffering from Parkinson's disease, and compared with the data obtained in an age-matched group of healthy controls. The controls were more sensitive at all spatial frequencies tested than the patients. The statistical comparisons were highly significant, indicating general differences between the PD patients and the controls not related to individual spatial frequency channels. When comparing the sensitivity loss between low and high spatial frequencies no significant differences were found suggesting that the decrease in contrast sensitivity is a global effect. We controlled for effects of age and cerebral atrophy, and our findings cannot be accounted for by these factors. In addition, the amount of contrast sensitivity loss was not correlated with the severity of the disease. These global functional alterations appear to be related to the reduction of dopamine at various sites of the visual system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3028995

Source DB:  PubMed          Journal:  Hum Neurobiol        ISSN: 0721-9075


  8 in total

1.  Influence of dopamine deficiency in early Parkinson's disease on the slow stimulation multifocal-ERG.

Authors:  Anja M Palmowski-Wolfe; Maria Timoner Perez; Stefanie Behnke; Gerhard Fuss; Martin Martziniak; Klaus W Ruprecht
Journal:  Doc Ophthalmol       Date:  2006-06-22       Impact factor: 2.379

2.  Dopamine and serotonin in cat retina: electroretinography and histology.

Authors:  W Skrandies; H Wässle
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

3.  Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease.

Authors:  J Nguyen-Legros
Journal:  Surg Radiol Anat       Date:  1988       Impact factor: 1.246

4.  D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus.

Authors:  Yongqiang Zhao; Nicolas Kerscher; Ulf Eysel; Klaus Funke
Journal:  J Physiol       Date:  2002-02-15       Impact factor: 5.182

5.  Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

Authors:  V Leuzzi; S Rinalduzzi; F Chiarotti; P Garzia; G Trasimeni; N Accornero
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 6.  Consequences of variations in genes that affect dopamine in prefrontal cortex.

Authors:  Adele Diamond
Journal:  Cereb Cortex       Date:  2007-09       Impact factor: 5.357

7.  Effect of levodopa on the human dark adaptation threshold.

Authors:  I Gottlob; K Strenn; B Schneider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-10       Impact factor: 3.117

8.  α-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells.

Authors:  Elena Marrocco; Alessia Indrieri; Federica Esposito; Valeria Tarallo; Anna Carboncino; Filomena Grazia Alvino; Sandro De Falco; Brunella Franco; Maria De Risi; Elvira De Leonibus
Journal:  Sci Rep       Date:  2020-06-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.